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Abstract Large chondroitinsulphate-containing proteoglycan
(versican) isolated from rabbit lung was cleaved by purified
gelatinase A (MMP-2) and gelatinase B (MMP-9), as well as by
crude enzyme extract from rabbit lung with hydraulic edema.
Gelatine zymography, performed after purification of gelatinases
by affinity chromatography, demonstrated that the enzyme
extract contained two main gelatinolytic bands at about 92
kDa and 72 kDa, identified by specific antisera as the latent
proMMP-9 and proMMP-2, respectively. Moreover, enzyme
extract from edematous lung showed an increased amount of the
proteolytically activated forms of both gelatinases with respect to
normal controls. These results suggest that MMP-2 and MMP-9
are involved in the breakdown of versican occurring in rabbit lung
during the development of hydraulic edema.
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1. Introduction
The ECM of lung interstitium provides a strong and ex-
pandable framework for the thin alveolar epithelial-capillary
intersection and consists mainly of collagen, elastic ¢bers and
PGs, which are largely responsible for tensile strength, elastic
recoil and tissue compliance, respectively [1]. The integrity of
ECM native architecture depends on the balance between the
regulation of synthesis and degradation of its components and
an excess of proteolytic activity over the inhibitory capacity of
the lung is likely to lead to parenchymal destruction.
The turnover and remodeling of lung ECM involves a fam-
ily of structurally related zinc-dependent endopeptidases, that
are known as MMPs, are active at neutral pH and can col-
lectively degrade almost all components of ECM [2,3]. In
particular, the MMP subfamily of gelatinases (gelatinase A,
MMP-2 and gelatinase B, MMP-9) degrades denaturated col-
lagens such as gelatin, type IV collagen, ¢bronectin and elas-
tin [2,3] and was found to be involved in some pathological
processes, including pulmonary emphysema [4^6], interstitial
lung diseases [7] and hyperoxia-induced acute lung injury [8^
10].
Recently, we found that PGs were broken down during the
development of lung edema, induced in rabbits by i.v. saline
loading [11] and that PG breakdown involved mainly the
versican family of the ECM [12]. On this basis, the aim of
this study was to determine: (1) whether gelatinases may rec-
ognize as substrate the core protein of lung interstitium PGs;
(2) whether increased activities of gelatinases are involved in
the development of hydraulic pulmonary edema, accounting
also for PG breakdown.
We found that large PG (versican) extracted and puri¢ed
from rabbit lung was cleaved by puri¢ed MMP-2 and MMP-
9, as well as by an enzyme extract from rabbit lung with
hydraulic edema. This enzyme extract contained both
MMP-2 and MMP-9 as demonstrated by gelatine zymogra-
phy and by speci¢c antibodies. Moreover, the amount of the
proteolytically activated forms of both gelatinases was in-
creased in edematous lung relative to control.
2. Materials and methods
2.1. Materials
125I and iodo beads were purchased from Dupont-NEN (Boston,
MA, USA) and Pierce Chemicals (Rockford, IL, USA), respectively.
Seikagaku (Tokyo, Japan) supplied the depolymerising C-O lyase
chondroitinase ABC from Proteus vulgaris. Sigma (St. Louis, MO,
USA) supplied standard disaccharides employed in capillary electro-
phoresis analysis. Gelatin-Sepharose resin was from Pharmacia (Upp-
sala, Sweden). Puri¢ed proMMP-2 and proMMP-9 (from human
neuroblastoma cell cultures) were supplied by Chemicon (Temecula,
CA, USA). Speci¢c sheep antisera against MMP-2 and MMP-9 and
PVDF were from The Binding Site (Birmingham, UK) and BioRad
(Hercules, CA, USA), respectively. The other biochemicals and re-
agents were commercial products of the highest purity.
2.2. Experimental protocol
The experiments were performed on adult New Zealand rabbits
anesthetized and tracheotomized to allow spontaneous breathing
[11]. The control group of rabbits (C) did not receive any treatment,
whereas the other group of animals was let to develop lung edema by
slow infusion of saline solution into jugular vein (hydraulic edema,
H)[11]. Animals were killed by an overdose of anesthetic [11] after
180 min, then the lungs were excised, pooled into two groups (C and
H) and then cut into small slices [11]. Aliquots of the pooled lung
slices, representing about 10% of the total sample, were used to de-
termine the water content, by measuring wet weight to dry weight
ratio (W/D) [11]. The W/D ratios were: 5.2 þ 0.2 for C (n = 8) and
6.0 þ 0.4 (n = 4) for H, in agreement with previous determinations of
lung W/D ratio in control rabbits and in animals a¡ected with hy-
draulic edema, respectively [11].
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2.3. Isolation, characterization and radiolabelling of large
proteoglycans from normal rabbit lung
PGs were extracted from pooled lung slices of group C with 0.4 M
GuHCl and puri¢ed as previously reported [11]. Versican, the large
chondroitin sulphate-containing PG of the ECM, was then isolated by
gel-¢ltration on Sepharose CL-4B under dissociative conditions [11].
Versican identi¢cation was con¢rmed by capillary electrophoresis
analysis of unsaturated disaccharides released by chondroitinase
ABC digestion [12]. The analysis of molecular size distribution of
native GAG chains was performed by gel-¢ltration in HPLC, after
papain digestion of PG core protein and removal of protease-resistant
peptides by L-elimination [13]. This analysis was also performed on
PGs extracted from edematous lung specimens to evaluate whether
GAG chains have been degraded during the development of hydraulic
edema.
Versican was then radiolabelled with 125I [13].
2.4. Assay of versican sensitivity to gelatinases
Aliquots of 125I-versican (70 000 cpm) were incubated with 1 Wg
of either puri¢ed MMP-2 or MMP-9 in 50 mM Tris-HCl bu¡er,
pH 7.5, containing 5 mM CaCl2, for 18 h at 37‡C. 125I-versican
degradation was then evaluated by gel-¢ltration chromatography on
Sepharose CL-4B column (50U1 cm, £ow rate 6 ml/h) under disso-
ciative conditions [11], determining the changes in elution pattern of
the radioactive material in comparison to the control untreated sam-
ple.
2.5. Preparation of crude enzyme extracts from lungs and assay of
versican degrading enzyme activities
Lung specimens were washed carefully, homogenized at 4‡C in
50 mM Tris-HCl bu¡er, pH 7.5, containing 150 mM NaCl, 0.002%
Tween-20, (bu¡er A) [14] and cleaned by centrifugation at 12 000Ug
for 10 min. Aliquots (100 Wg protein) of the crude enzyme extract
from H group were incubated with 125I-versican (70 000 cpm) for
18 h at 37‡C in 50 mM Tris-HCl bu¡er, pH 7.5, containing 5 mM
CaCl2. Versican degradation was then evaluated by gel-¢ltration chro-
matography on Sepharose CL-4B as reported above.
2.6. Radioactivity measurements
125I-radioiodinated materials were monitored by a Cobra II Q-coun-
ter (Canberra Packard).
2.7. Puri¢cation of gelatinases by a⁄nity chromatography
Aliquots of the crude enzyme extracts from C and H groups were
incubated with gelatin-Sepharose resin (100 Wg protein/100 Wl resin)
for 1 h at 4‡C under gentle mixing to isolate gelatin degrading en-
zymes [14]. The resin was then recovered, washed carefully with bu¡er
A, containing 5 mM CaCl2 and 10 mM Na2-EDTA, resuspended in
4ULaemli sample bu¡er and used for electrozymograms.
2.8. SDS-PAGE zymography
SDS-PAGE was performed using 10% (w/v) gel copolymerized with
gelatin (1 mg/ml) [14] to identify proteins with gelatinolytic activities.
After washing and overnight incubation of the gel at 37‡C in an
activating bu¡er (50 mM Tris-HCl bu¡er, pH 7.5, containing
200 mM NaCl and 5 mM CaCl2), the gel was stained with 0.5%
(w/v) Coomassie Brilliant Blue R-250 [14]. Proteolytic activities were
detected as clear bands against the blue background, indicating areas
where gelatin was degraded by the enzymes. The area of the gelati-
nolytic bands was evaluated by a GS 700 densitometer (BioRad) and
showed a linear increase with increasing amounts of standard MMPs
(from 0.2 to 1 Wg, regression coe⁄cient (r2) = 0.90 þ 0.04). The molec-
ular weights of gelatinolytic bands were estimated by comparing their
electrophoretic migration to that of protein standards (BioRad). To
analyze metalloproteinase inhibition, the gels were incubated in the
presence of 20 mM EDTA.
Immunoblot analysis was performed after SDS-PAGE, carrying out
Western transfer to PVDF using a semi-dry transfer cell (BioRad) at
15 V/cm2 for 20 min. The identi¢cation was then performed with
speci¢c polyclonal sheep antibodies (1:5000), which reacted with
both the zymogen latent forms and the proteolytically activated forms
of these enzymes. The positive bands were revealed by chemilumines-
cence (Super Signal Pierce) after incubation with antisheep donkey
antibodies conjugated with horseradish peroxidase.
3. Results
3.1. Versican degradation by puri¢ed gelatinases and by crude
enzyme extract from edematous rabbit lung
Gel-¢ltration chromatography of 125I-versican isolated from
normal rabbit lung on Sepharose CL-4B under dissociative
conditions showed that the radioactive material was eluted
in the void volume of the column (Fig. 1, panel C). The in-
cubation with puri¢ed MMP-2, MMP-9 and crude enzyme
extract from edematous rabbit lung resulted in a fragmenta-
tion of 125I-versican, as the amount of radioactive material
eluted in the void volume of the column was markedly re-
duced (365.4%, 350.1% and 378.5% relative to control C,
respectively) (Fig. 1, panels MMP-2, MMP-9 and H). The
degradation products were likely represented by peptidogly-
cans. In fact, gel-¢ltration HPLC analysis of native GAG
chains from control and edematous lungs showed that the
chain size was dispersed within the same range of values.
Low molecular size material referable to oligosaccharides
was not detected in these GAG preparations, indicating that
the breakdown of PGs during the development of hydraulic
edema depended only on the degradation of core protein.
3.2. SDS-PAGE zymography
Gelatin zymography revealed di¡erent gelatinolytic bands
in the puri¢ed enzyme extracts from C and H groups (Fig.
2, panel A, lanes 3 and 4). The bands at about 72 kDa (band
a) and 92 kDa (band b) corresponded to standards of latent
proMMP-2 and proMMP-9, respectively (Fig. 2, panel A,
lane 2) and showed enlarged areas in H group with respect
to C (compare lane 4 and lane 3). The two minor, faster
migrating bands (bands aP and bP) likely represented the pro-
teolytically activated forms of the enzymes and were more
evident in H group.
The bands of higher molecular mass are known to be in-
cluded in the typical zymography pattern of MMP-9 from
neutrophils [4,5,15,16]. The 135 kDa band (band c) was
Fig. 1. Sepharose CL-4B dissociative gel-¢ltration chromatography
of 125I-versican extracted and puri¢ed from normal rabbit lung. 125I-
versican incubated with bu¡er only (panel C); 125I-versican incu-
bated with puri¢ed MMP-2 (panel MMP-2); 125I-versican incubated
with puri¢ed MMP-9 (panel MMP-9); 125I-versican incubated with
enzyme extract from edematous lung (panel H). Determination of
cpm is expressed in thousands.
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shown to be a complex of 92 kDa MMP-9 and a 25 kDa
protein, named neutrophil gelatinase-associated lipocalin
[16], whereas the larger ones (s 200 kDa, bands d and e)
consisted probably of multiple forms of the enzyme [4,5,16].
Also these bands were more evident in H group with respect
to C.
No gelatinolytic bands were detectable when the gels were
incubated in the presence of 20 mM EDTA, a typical inhibitor
of MMPs (Fig. 2, panel A, lane 5).
The identi¢cation of the gelatinolytic bands was con¢rmed
by speci¢c antisera in the puri¢ed enzyme extract from C and
H groups. In the case of immunoblotting detection of MMP-
2, the antibody reacted with the band of 72 kDa and with
some lower molecular mass degradation products (Fig. 2, pan-
el B, lanes 6 and 7). The antibody against MMP-9 recognized
both the zymogen latent form and the proteolytically acti-
vated form of the enzyme, as well as its higher molecular
mass forms and some degradation products (Fig. 2, panel B,
lanes 8 and 9).
4. Discussion
This study provides direct evidence that large chondroitin-
sulphate-containing PG (versican) puri¢ed from lung intersti-
tium is sensitive to MMP-2 and MMP-9 activity. Both MMP-
2 and MMP-9 were previously shown to cleave the large PG
of cartilage (aggrecan) [17^20], the activity of MMP-9 being
lower [17]. In agreement with these ¢ndings, we found that
versican degrading activity of MMP-2 was higher than that of
MMP-9 (Fig. 1).
Gelatinases are expressed in normal adult tissues and an
immunohistochemical study of normal lung showed that
MMP-2 and MMP-9 are localized in ciliated cells, endothelial
cells, pneumocytes, macrophages and smooth muscle cells,
whereas ¢broblasts show a strong reaction only for MMP-2
[21]. The enzyme extract from edematous rabbit lung was able
to cleave versican from lung samples of the same animal and
displayed both MMP-2 and MMP-9 activities, indicating that
gelatinases recognize as a substrate in vivo also the large PG
family of lung interstitium.
An upregulation of gelatinases was shown to be involved in
both chronic and acute lung injury [4^10]. Our data indicate
that an increase of both MMP-2 and MMP-9 activity is in-
volved in the development of pulmonary edema induced by
saline infusion, sharing the massive fragmentation of versican
occurring in this type of edema [11,12].
The pattern of gelatine zymography of lung enzyme extracts
included the 135 and s 200 kDa forms, which are character-
istic of MMP-9 of neutrophil origin [4,5,15,16]. A large body
of evidence implicates neutrophils in the acute respiratory
distress syndrome that often follows systemic in£ammation
[22]. Our ¢nding indicates that neutrophils are likely to take
part in damaging pulmonary interstitium PGs during the de-
velopment of hydraulic edema.
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